Why the Difference Between Risk and Hazard Matters for Nanotechnology
April 23, 2007
Scientific progress is a balancing act: Weigh the empirical evidence and determine the appropriate balance between allowing new technologies and protecting public health. Periodically however, development is obstructed by fear diminishing physical data. In this article, Mark Mansour discusses the idea that nanotechnology is poised to turn a bad trend of regulators, preferring to use “precautionary principles” to regulate based on means of production rather on the safety of the product, on its head and show the world that regulation based on empirical data, rather than on fear, provides the best hope for a safe future.
Copyright 2007 Small Times, PennWell Corp.
Copyright 2007 Small Times, PennWell Corp.
Related Insights
July 25, 2025
Foley Viewpoints
Thorny Laws That ICHRA Vendors Should Consider, Part Three: FinTech Edition
We continue our series on the legal and regulatory challenges facing individual coverage health reimbursement arrangements (ICHRAs); this…
July 24, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
July 23, 2025
Foley Viewpoints
The One Big Beautiful Bill and Workplace Immigration Enforcement
The “One Big Beautiful Bill Act,” signed into law by President Trump on July 4, 2025, will fund government efforts to continue to…